Lisanti Capital Growth LLC purchased a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 13,590 shares of the company’s stock, valued at approximately $1,282,000. Other institutional investors have also modified their holdings […]
Guggenheim Capital LLC Grows Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-one research firms that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and sixteen have given a buy recommendation to the company. The average 1 year […]
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-one analysts that are presently covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The average […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its target price dropped by stock analysts at Mizuho from $116.00 to $114.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Mizuho’s target price points to a potential upside of 6.37% from the stock’s current price. […]